Disruption to this axis, even temporarily, may manifest as cycle irregularities or intermenstrual bleeding
This could include dietary changes, supplements, or, in some cases, adjusting your medication
It is unknown whether Wegovy causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined Wegovy is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
If additional glycemic control is needed, the dose can be increased to 1 mg once weekly after at least four weeks, and further to a maximum of 2 mg once weekly if necessary
Novo Nordisks CagriSema led to 23% weight loss but missed industry expectations, sending its stock tumbling